Network origin in Michael Cook first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Cook via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DIAMEDICA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Pharmaceuticals: Major | Founder | |
PFB CORPORATION | Building Products | Director of Finance/CFO | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Toronto Stock Exchange, Inc.
Toronto Stock Exchange, Inc. Investment Banks/BrokersFinance Toronto Stock Exchange operates as a stock exchange. It provides opportunities to access public equity capital, liquidity for existing investors, and monitor market exposure associated with Canada's senior exchange. Toronto Stock Exchange was founded in 1852 and is located in Toronto, ON. | Investment Banks/Brokers | President | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
Elon University | College/University | Undergraduate Degree | |
University of Toronto | College/University | Doctorate Degree | |
University of Calgary | College/University | Undergraduate Degree | |
AVIVAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Aston | College/University | Doctorate Degree | |
PACGEN LIFE SCIENCE CORPORATION | Biotechnology | Director/Board Member | |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
Institute of Chartered Accountants of Alberta | Corporate Officer/Principal | ||
Shaw Festival Theatre
Shaw Festival Theatre Movies/EntertainmentConsumer Services Shaw Festival Theatre operates as a non profit organization that engages in performing art theatres. The company was founded by Brian Doherty in 1962 and is headquartered in Niagara-on-the-Lake, Canada. | Movies/Entertainment | Director/Board Member | |
YM Biosciences USA, Inc.
YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Pharmaceuticals: Major | Chairman | |
Loewen, Ondaatje, McCutcheon Ltd.
Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Loewen, Ondaatje, McCutcheon Ltd. (LOM) is an independent Canadian broker/dealer firm headquartered in Toronto, Ontario. Founded in 1970, the firm combines objective research and value-added financing ideas with institutional sales, trading and investment banking. They are a provider of value-added North American research. LOM focuses exclusively on advising small and mid-cap companies, with a strong focus on select emerging growth companies in industries that include Technology, Healthcare, and Mining. | Investment Banks/Brokers | Director/Board Member | |
Lifeline Technologies, Inc.
Lifeline Technologies, Inc. BiotechnologyHealth Technology Lifeline Technologies, Inc. operates as a health sciences development company which focuses on novel strategies. It offers ChoLESStolife, a non-prescription and non-synthetic cholesterol absorption inhibitor for the reduction of human cholesterol using a fat-free delivery system for soy sterols and stanols. The company was registered by Curtis A. Spilburg and Richard E. Ostlund on October 1, 2002 and is headquartered in Hendersonville, NC. | Biotechnology | Director/Board Member | |
Norwich Eaton Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
Networks of Centres of Excellence
Networks of Centres of Excellence Miscellaneous Commercial ServicesCommercial Services Networks of Centres of Excellence offers programs that focuses on research and development. The company was founded in 1989 and is headquartered in Ontario, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Tarix Pharmaceuticals Ltd.
Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Retrotope, Inc.
Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
OCAD University | College/University | Director/Board Member | |
Knowledge Based Industries Group | Founder | ||
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Investment Managers | Corporate Officer/Principal | |
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Life Sciences Ontario | Director/Board Member | ||
Canadian Society For Clinical Investigation | President | ||
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Founder | |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Investment Managers | Private Equity Investor | |
Cresswell Advisors, Inc.
Cresswell Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Cresswell Advisors, Inc. provides assistance and direction to development-stage companies in the life sciences and for earlier-stage companies in multiple fields. It also offers strategic advisory, negotiation and completion, project management, business development, regulatory compliance, corporate governance, financing strategies, and recruitment services. The company was founded in 1981 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder | |
Bristol-Myers Squibb FCT bêta, Inc.
Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member |
Statistics
International
Canada | 25 |
United States | 20 |
United Kingdom | 6 |
Ireland | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 6 |
Producer Manufacturing | 2 |
Operational
Director/Board Member | 38 |
Corporate Officer/Principal | 14 |
President | 9 |
Chairman | 8 |
Chief Executive Officer | 8 |
Most connected contacts
Insiders | |
---|---|
Peter G. Milner | 18 |
David Allan | 16 |
Niclas Stiernholm | 13 |
Henry Friesen | 12 |
Dan Stearne | 8 |
Alan Moore | 6 |
- Stock Market
- Insiders
- Michael Cook
- Company connections